Scientists developed an in situ sustained-release hydrogel delivery system for combined chemo-immunotherapy of glioma by combined chemotherapy drug and immunoadjuvant through the resection cavity local delivery.
[Journal of Controlled Release]
Sorry, but the selected Zotpress account can't be found.
